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Cytochromes c are ubiquitous proteins, essential for life in
most organisms. Their distinctive characteristic is the covalent
attachment of heme to their polypeptide chain. This post-trans-
lational modification is performed by a dedicated protein sys-
tem, which in many Gram-negative bacteria and plant mito-
chondria is a nine-protein apparatus (CcmA–I) called System I.
Despite decades of study, mechanistic understanding of the
protein–protein interactions in this highly complexmaturation
machinery is still lacking. Here, we focused on the interaction of
CcmC, the protein that sources the heme cofactor, with CcmE,
the pivotal component of System I responsible for the transfer of
the heme to the apocytochrome. Using in silico analyses, we
identified a putative interaction site between these two proteins
(residues Asp47, Gln50, and Arg55 on CcmC; Arg73, Asp101, and
Glu105 onCcmE), andwe validated our findings by in vivo exper-
iments inEscherichia coli.Moreover, employingNMR spectros-
copy, we examined whether a heme-binding site on CcmE con-
tributes to this interaction and found that CcmC and CcmE
associate via protein–protein rather than protein–heme con-
tacts. The combination of in vivo site-directed mutagenesis
studies and high-resolution structural techniques enabled us to
determine at the residue level the mechanism for the formation
of one of the key protein complexes for cytochrome c matura-
tion by System I.
c-Type cytochromes have a central role in all kingdoms of life
due to their involvement in essential cellular processes (1, 2).
Primarily, they function as electron carriers in both aerobic and
anaerobic respiration. In eukaryotes, mitochondrial cyto-
chrome c shuttles electrons from the bc1 complex to cyto-
chrome c oxidase during aerobic respiration, ultimately gener-
ating a proton electrochemical gradient across the membrane,
which drives ATP synthesis (3). In bacteria, where respiration
can be performed by several different pathways, cytochromes c
usually have a role in quinol-oxidizing steps (4). In addition to
their classical electron transport function in respiration and
photosynthesis, c-type cytochromes have also been assigned
roles in other important biological processes, like triggering
apoptosis in mammalian cells (5), assembling the mitochon-
drial cytochrome c oxidase (6), and scavenging H2O2 in yeast
and Gram-negative bacteria (7). They are found inmost organ-
isms, and, in prokaryotes especially, they exhibit an impressive
range of shapes, sizes, and heme content (8). Unlike other com-
monly encountered heme-containing proteins, the distinguish-
ing characteristic of cytochromes c is that at least one of their
heme groups is always covalently and stereospecifically bound
to two cysteines of a conserved CXXCHmotif (9). This attach-
ment occurs as a post-translational modification, after the apo-
cytochrome (protein without heme) is translocated to the bio-
logical compartment in which it will function as a holoenzyme
(protein with heme).
Despite the relatively simple chemical nature of the covalent
bonds in cytochromes c, the maturation process itself is very
elaborate, as it relies on multiple complex steps, including pro-
tein translocation and folding, post-translational modification,
redox homeostasis, and cofactor acquisition, transfer, and
insertion into the polypeptide chain. Unsurprisingly, living
organisms employ several different cytochrome c maturation
(Ccm)4 systems to perform this task (10–14). System I, found in
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most Gram-negative bacteria and plant and protozoal mito-
chondria, is undoubtedly the most complex of the Ccm appa-
ratuses, possibly accounting for the vast diversity of bacterial
cytochromes c and the fact that often one bacterial species will
encode several entirely different c-type cytochromes (8). Sys-
tem I comprises nine proteins, CcmA–I, which in Gram-nega-
tive bacteria are located in the inner membrane or have protein
domains oriented into the periplasm; CcmA is an exception,
and it is found on the cytoplasmic side of the inner membrane.
A schematic representation of System I is shown in Fig. 1.
Essential roles for almost all proteins of System I have been
assigned (15–18), and their function has been extensively
reviewed (12, 19–21). More recently, a modular approach has
been adopted whenever System I is described (12, 14, 21). The
first module, CcmA–E, deals with heme transport and provi-
sion. Although the transport route of the heme to the periplasm
for cytochrome c biogenesis purposes remains unknown,
CcmC is thought to be the protein responsible for sourcing the
heme for System I (22, 23). Along with CcmD, heme-bound
CcmC forms a complex with the heme chaperone CcmE (22–
24). In the environment of this protein complex, CcmE binds
the heme covalently through a conserved histidine residue (25).
The CcmC–heme–CcmE complex is subsequently resolved
through the ATPase activity of CcmA and presumably confor-
mational rearrangements involving CcmB (26, 27). CcmG and
CcmH (which in Escherichia coli, the model organism for
studying System I, is fused with CcmI; Fig. 1) form a second
module responsible for thio-redox control of the substrate apo-
cytochrome. This is essential because the action of the oxidase
DsbA on the two cysteines of the CXXCH apocytochrome
motif needs to be counteracted before heme attachment (28–
30). Finally, CcmF, CcmH, and CcmI form the third System I
module. These proteins are involved in binding the apocyto-
chrome and bringing it into contact with holo-CcmE in order
for heme to be transferred and stereospecific heme attachment
to take place (31–34). CcmI is proposed to have a chaperone
role binding the apocytochrome (34), and CcmF, which con-
tains its own noncovalently bound heme (22), is thought to be
the “heme lyase” of System I, although amechanism has not yet
been proposed.
Protein–protein interactions between the components of
System I must be key to its cytochrome c biogenesis function.
Currently, it is not clear whether the proteins of this system
form one large supercomplex or are organized in several
smaller modules as described above. Both hypotheses are plau-
sible and have been proposed in the literature (21, 35). Several
interactions between proteins of System I have been experi-
mentally validated (recently reviewed comprehensively by Ver-
issimo and Daldal (21)), as have both covalent and noncovalent
protein–heme interactions (22, 24, 36). However, the lack of
structural information on this system is striking (only the struc-
tures of apo-CcmE (37), CcmG (38), CcmH (39), and an analog
of CcmI (40) have been determined). Therefore, mechanistic
details on protein–protein interactions, even pairwise asso-
ciations between known protein partners, remain largely
uncharacterized.
In this study, we focus on the interaction of CcmC with
CcmE, which leads to holo-CcmE formation. This protein pair
is one of the most studied in bacterial cytochrome c biogenesis.
CcmC and CcmE, along with the small polypeptide CcmD (Fig.
1), are known to associate in a stable complex, which, when
purified, contains heme (22, 24). AlthoughCcmCdoes not bind
heme stably in the absence of CcmE, the formation and isola-
tion of the CcmC–heme–CcmE complex is not dependent on
Figure 1. Cytochrome c biogenesis System I is a multiprotein apparatus (CcmA-I) predominantly located in the inner membrane and periplasm of
Gram-negative bacteria. Shown is a schematic representation of its main components based on the model organism E. coli. Proteins that are known to bind
heme (red squares) covalently or noncovalently are depicted in red or green, respectively, whereas proteins that are thought to be involved in reductant
provision are depicted in yellow. Apocytochrome c (in black) is synthesized in the cytoplasm and transported across the cytoplasmic membrane by the Sec
apparatus (65). Heme is also synthesized in the cytoplasm, but its transport route to the point of assembly is unknown (indicated by a question mark). In most
System I–containing organisms, CcmH and CcmI are two differentmembrane-anchored proteins; in E. coli, CcmH and CcmI are fused into one protein, usually
referred to as CcmH.
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the heme-binding histidine of CcmE (22). The exact role of
CcmD in this process remains enigmatic, but it has been shown
that whereas it is not required for covalent attachment of heme
toCcmE, its presence is essential for release of the holo-product
(41). Despite several studies on these protein partners, there are
still many unknowns regarding the association of CcmC with
CcmE.What drives this interaction? Do CcmC and CcmE bind
to each other through specific residues? Or is the formation of
theCcmC–heme–CcmEcomplexmediated by the heme that is
bound on CcmC and a heme-binding site on CcmE? Here, we
employ in silico analyses to look for an interaction site between
the two proteins and validate our findings in E. coli using site-
directed mutagenesis in an in vivo experimental system. We
complement our in vivo experiments with NMR spectroscopy
to study the interaction of apo-CcmE with heme in vitro and to
assess the presence of a heme-binding site on this protein. This
combined approach allows us to answer all of the above ques-
tions in a definitive manner and to elucidate the mechanism of
one of the crucial steps of cytochrome cmaturation by System I.
Results
Covariance and bioinformatic analyses identify a putative
CcmC–CcmE interaction site
In 2014,Ovchinnikov et al. (42) found that amino acid coevo-
lution analysis could be used to predict whether two proteins
interact. More specifically, it was shown that residue–residue
covariance occurs frequently between physically interacting
protein pairs and rarely between noninteracting proteins.
Within this study, a prediction of interacting protein partners
of unknown structure was performed for the E. coli proteome,
and a particular pair of residues, Gln49 in CcmC and Arg104 in
CcmE, scored the highest in this analysis (see Fig. 3 of Ovchin-
nikov et al. (42)); neither CcmC nor CcmE was highlighted in
any of the other predicted interactions. In the context of the
Ovchinnikov et al. study (42), this result was relatively unsur-
prising becauseCcmCandCcmEare known to interact (22, 24).
However, as the mechanism of interaction between these two
proteins remains unknown, this prediction was exciting
because it indicated a high probability for the presence of a
CcmC–CcmE interaction site involving these two residues.
We sought to assess the role of CcmC Gln49 and CcmE
Arg104 by using site-directed mutagenesis on the entire E. coli
System I operon and examining the levels of holo-CcmE and
holocytochrome c matured in vivo. We initially generated sin-
gle-amino acid substitutions, where each of the two amino
acids was replaced by an alanine. Surprisingly these mutations
did not seem to have a very strong effect on System I function.
Whereas holo-CcmE levelswere slightly elevated for theQ49A-
CcmC variant, they remained unaffected for the R104A-CcmE
variant. In addition, holocytochrome c (holo-c550) levels were
comparable with the WT System I for both variants (lanes 1–3
in Fig. 3A; a full description of this figure will follow). Taken
together, these results suggest that these residues are not essen-
tial for the formation of a functional CcmC–CcmE complex.
Reasoning that the amino acids involved in the interaction
surface of the two proteins could be near the covarying pair, we
turned to bioinformatics.We searched in bacterial and archaeal
representative proteomes for homologs of E. coli CcmC and
CcmE and identified conserved amino acids that couldmediate
protein–protein interactions and were in the same part of the
proteins as the residues identified by the covariance analysis.
For E. coliCcmC, Asp47 (in87% of cases, it is either an Asp or
a Glu), Gln50 (65% conservation), and Arg55 (it is either an
Arg or a Lys) were plausible candidates (Fig. S1). For E. coli
CcmE,Asp101 (in64%of cases, it is either anAsp or aGlu) and
Glu105 (in 84% of cases, it is either a Glu or an Asp) were
chosen (Fig. S2). The rationale behind considering these amino
acids was their high conservation and their ability to form elec-
trostatic or hydrogen bond interactions. As only two putative
interacting amino acids could be selected for CcmE, we also
examined the solution NMR structure of this protein (37) and
searched for a third candidate, ideally one that would be posi-
tively charged or capable of forming a hydrogen bond with a
negatively charged residue. We based this on the nature of the
amino acidswe had already identified onCcmCandwehypoth-
esized that, although we could not assign specific amino acid
pairs, most likely Gln50 and Arg55 of CcmC would be interact-
ing with Asp101 and Glu105 of CcmE. Thus, we were looking for
a partner for Asp47. We identified CcmE Arg73 (in 58% of
cases, it is either an Arg or a Lys) as a potential candidate.
Although this residue is not near Arg104 in the primary
sequence (Fig. S2), it is located near it and near Asp101 and
Glu105 in the 3D structure of apo-CcmE (see Fig. 4B).
Three pairs of amino acidsmediate the CcmC–CcmE
interaction and are collectively essential for holo-CcmE and
holocytochrome c formation
The presence of an interaction site betweenE. coliCcmCand
CcmE was tested in vivo using variant System I operons where
each of the six identified residues (Asp47, Gln50, and Arg55 on
CcmC; Arg73, Asp101, and Glu105 on CcmE) was replaced by an
alanine. We observed identical results for the maturation of
holo-CcmE and holo-c550 for all tested variant operons. Holo-
CcmE decreased significantly (lanes 2–4 in Fig. 2 (A and B), top
gel strip) compared with the level matured by theWT System I
(seen in lane 1). Holo-c550 amounts were also significantly
reduced (lanes 2–4 in Fig. 2 (A and B),middle gel strip), reflect-
ing the decrease in holo-CcmE.Total CcmC (Fig. 2A, bottom gel
strip) and CcmE (Fig. 2B, bottom gel strip) levels in all variants
were assessed by immunoblotting and were found to be unaf-
fected by the amino acid replacements.
The results from the single-amino acid substitutions indicate
involvement of these residues in the interaction of CcmC with
CcmE. To assess their collective role, we investigated whether
removal of all three of them on one of the protein partners
would abolish the residual holo-CcmE amount obtained with
the single variants (Fig. 2 (A and B), top). We carried this out by
mutating residues in CcmE (R73A/D101A/E105A mutation;
Fig. 2C) and found that production of holo-CcmE and holo-c550
was entirely abolished (lane 2 in Fig. 2C, top and middle gel
strips), whereas the total CcmE amount remained unaffected
(lane 2 in Fig. 2C, bottom gel strip). Thus, we can conclude that
the interactions between Asp47, Gln50, and Arg55 of CcmC and
Arg73, Asp101, and Glu105 of CcmE are collectively essential for
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the successful association of the two proteins, leading to matu-
ration of CcmE and cytochrome c.
CcmCGln49 interacts with CcmE Arg104, and this interaction
ensures efficient holo-CcmE release from the CcmC–heme–
CcmE complex
After validating the CcmC–CcmE interaction site, we turned
back to the residues identified by the covariance analysis (Gln49
inCcmCandArg104 inCcmE) (42), whose role was still unclear.
Our single-amino acid substitutions left holo-c550 amounts
(lanes 2 and 3 in Fig. 3A,middle gel strip) unaffected compared
with the amounts generated by the WT System I (seen in lane
1). However, a double-alanine mutant led to a dramatic out-
come; substantial accumulation of holo-CcmE was observed
(lane 4 in Fig. 3A, top gel strip), but holo-c550 production was
entirely abrogated (lane 4 in Fig. 3A, middle gel strip). Total
CcmE amounts were assessed by immunoblotting for all con-
structs and were found to be unaffected (Fig. 3A, bottom gel
strip).
The effect observed for the double-substitution is strongly
reminiscent of the phenotype of the K40D-CcmA mutation,
abolishing the ATPase activity of CcmA (26, 27). This suggests
that CcmCGln49 and CcmEArg104 are likely playing an impor-
tant role in the release of holo-CcmE from the CcmC–heme–
CcmE complex. To further explore this hypothesis, we gener-
ated a series of System I variants and examined the amount of
holo-c550 produced in vivo; in this experimental setting, WT
levels of holo-c550 indicate that the substitution in question
does not affect theCcmC–CcmE interaction and System I func-
tion. The mutations that were assessed are summarized in
Table 1. We found that swapping the positions of the tested
residues (Q49R-CcmC/R104Q-CcmE) or significantly altering
their polarity (Q49E-CcmC and Q49I-CcmC/R104I-CcmE)
had no effect (Fig. 3B). Several other mutations (Table 1),
including double serine and cysteine substitutions (Fig. 3C),
also did not affect System I function. We were only able to
reproduce the result observed with the double-alanine substi-
tution (Fig. 2A) when we replaced one or both alanines in this
variant with a valine residue (Fig. 3D, lanes 2–4). For these
mutants, we observed holo-CcmE accumulation and lack of
holo-c550 production (top and middle gel strips), whereas total
CcmE amounts remained unaffected (bottom gel strip).
Considering the outcome of our mutagenesis experiments
(Table 1), the exact role of CcmCGln49 and CcmEArg104 is not
clear. These residues are likely to interact, confirming the pre-
diction by Ovchinnikov et al. (42). However, the interaction
does not involve electrostatics or hydrogen bonding because
replacement of both residues by isoleucine gave WT behavior
(Table 1 and Fig. 3B). Surprisingly, double serine or cysteine
Figure 2. The putative interaction site between CcmC and CcmE can be
validated by in vivo experiments in E. coli. A, replacement of Asp47, Gln50,
or Arg55 by alanine in CcmC leads to decrease in holo-CcmE and holo-c550. B,
replacement of Arg73, Asp101, or Glu105 by alanine in CcmE leads to a decrease
in holo-CcmE and holo-c550. C, replacement of all putative CcmE interaction
residues (Arg73, Asp101, and Glu105) by alanines abrogates holo-CcmE and
holo-c550 formation. Levels of total CcmCandCcmE are not affected by any of
the mutations. For all panels, representative SDS-PAGE of cell membranes or
periplasmic fractions stained for proteins containing covalently bound heme
(top andmiddle gels of each panel) and immunoblotted to detect total CcmC
or CcmE amounts (bottom gel of each panel) are shown. Molecular weight
markers (M) are on the left.
Figure 3. The covarying residues, Gln49 and Arg104 in CcmC and CcmE,
respectively, are involved in the release of holo-CcmE after covalent
heme attachment. A, single replacements of Gln49 and Arg104 by alanine do
not affect holo-c550 levels, but a double variant leads to holo-CcmE accumu-
lation and abrogation of cytochrome cmaturation. B, swapping the positions
of Gln49 and Arg104 on CcmC and CcmE or altering their polarity does not
affect holo-c550 levels. C, replacement of Gln
49 andArg104 on CcmC andCcmE
by serines or cysteines does not affect holo-c550 levels. D, replacement of the
covarying pair by an alanine and a valine or two valine residues recapitulates
thephenotypeobserved in lane4ofA. Levels of total CcmEarenot affectedby
any of the mutations. Representative SDS-PAGE of cell membranes or
periplasmic fractions stained for proteins containing covalently bound heme
(B and C and top and middle gels of A and D) and immunoblotted to detect
total CcmE amounts (bottom gel of A and D) are shown. Molecular weight
markers (M) are on the left; the samemarker lane was used for themiddle gel
of A and for C. Gaps indicate where a lane was removed.
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substitutions (Fig. 3C), which are similar in side-chain volume
to the double alanine or alanine/valine substitutions, did not
elicit the phenotype observed in Fig. 3A (lane 4) and Fig. 3D
(lanes 2–4) either, suggesting that side-chain size alone is not
the determinant of the interaction. In the absence of a structure
for CcmC, it is difficult to propose an exact function for the
Gln49-CcmC-Arg104-CcmE pair. Nonetheless, we can suggest
that these residues could play a steric role that would ensure
that other residues in the CcmC–CcmE interaction surface are
optimally placed for the release of holo-CcmE after heme
attachment.
Bioinformatic analysis of the amino acids found at these posi-
tions in close homologues of E. coliCcmC and CcmE from bac-
teria and archaea (Table S2) shows that they can be occupied by
a broad range of residues; however, the combinations that we
identified as ones that are detrimental to System I functionwere
not found to occur. We tested one of the alternative combina-
tions that we identified bioinformatically for this pair (Q49K-
CcmC/R104A-CcmE-System I variant) and found it to behave
like theWTSystem I in terms of holo-c550 production (Table 1),
confirming that several combinations of amino acids in these
positions lead to a functional Ccm system.
Holo-CcmE does not have a heme-binding site on the protein
core
Our in vivo experiments showed that holo-CcmE formation
depends on the association of CcmC with CcmE through six
residues, three on each protein partner. This suggests that the
interaction of CcmC with CcmE is independent of the heme
moiety, as none of these System I residues have ever been found
to be involved in heme binding. The location of these amino
acids on CcmC and CcmE corroborates this assumption (Fig.
4). The structure of CcmChas not been determined; however, a
reliable topological prediction has been proposed previously
(43). Based on this topology model, on which we mapped the
identified interaction residues and the covarying residue Gln49
(Fig. 4A), the CcmE interaction site does not coincide with the
heme-binding site of CcmC, although it is sufficiently close for
a productive subsequent interaction. The same can be con-
cluded when the CcmE interacting residues are mapped on the
3D structure of the protein (Fig. 4B); these amino acids along
with the covarying Arg104 form a tight cluster located on a flex-
ible loop placed above His130, the E. coli CcmE heme-binding
residue.
Nonetheless, the idea that CcmEhas a heme-binding site and
that its affinity for the heme moiety drives its association to
heme-bound CcmC has been proposed numerous times.
Attempts to validate this hypothesis have included a variety of
techniques (37, 44–46), whereas residue-specific insight was
provided byNMR spectroscopy andmodeling (37). In the latter
study, residues Ile34, Phe37, Arg61, and Val110, some of which
are located in the protein -barrel core, along with Leu127 and
Lys129, which are part of its flexible C terminus (all shown in
magenta in Fig. 4B), were postulated to form a heme-binding
site. Some of these findings were validated in vivo in another
study, using a minimal experimental system expressing only
CcmC and CcmE (44). As these results are not consistent with
our CcmC–CcmE interaction model, we employed NMR spec-
troscopy to re-examine the interaction of heme with soluble
CcmE in vitro and to investigate whether a heme-binding site
could be involved in its interaction with CcmC.
Initially, we used a protein construct similar to that used by
Enggist et al. (37) (i.e. leaderless (Ser32–Ser163) E. coli CcmE
bearing a C-terminal His6 tag). However, instead of purifying
the holoprotein after co-expression of soluble CcmE with Sys-
tem I, we purified it in its apo-form and fully reconstituted it
with heme in vitro. The advantage of this approach is that we
were certain that our sample contained solely WT holo-CcmE;
we generally find that separation of mixtures of holo- and apo-
CcmE produced in vivo is particularly challenging and never
occurs fully. After staining our protein for covalently bound
heme, we further characterized our sample by visible absorp-
tion spectra with and without hydroxide and pyridine in reduc-
ing heme conditions and found it to have the sameheme attach-
ment as in naturally occurring CcmE (Fig. S3A) (25). In
addition, we used MS, which also confirmed that our sample
only contained holo-CcmE. The heme in its oxidized state is
paramagnetic, sowe initially attempted to reduce the heme iron
with sodium dithionite (Sigma-Aldrich), as claimed by Enggist
et al. (37), before performing NMR experiments. However, we
found that it was not possible to keep the protein in its reduced
state, despite any measure taken against oxidation (degassed
buffer system, argon flushing, etc.). We therefore proceeded to
record 1H-15N heteronuclear single quantum coherence
(HSQC) spectra of 15N-labeled apo-CcmE and 15N-labeled oxi-
dized holo-CcmE (Fig. S3B) and assessed the effect of heme
binding by comparing individual peak intensities for all back-
bone residues. Proximity of an amino acid with the paramag-
netic heme should lead to peak broadening and decrease in the
peak height (Fig. S3C); therefore, a lower peak intensity ratio
should be observed for residues affected by the heme (Fig. 5A).
We found that residues in the core of the protein showed a
uniform level of nonspecific broadening that is to be expected
because of the presence of the heme in the sample. Pronounced
Table 1
Summary of results obtained by assessing the role of the covarying
residues Gln49 and Arg104 in CcmC and CcmE, respectively (42), by
mutagenesis on the entire E. coli System I operon and subsequent
quantification of the relative amounts of holo-CcmE and exogenously
expressed cytochrome c550 produced in vivo
For several variants, levels of holo-c550 were assessed first. WT amounts of c550
indicate that the mutation has no effect on the maturation process; in these cases,
quantification of holo-CcmE was omitted (entries marked with — in the “Holo-
CcmE level” column).
Variant
Holo-c550
level
Holo-CcmE
level
Q49A-CcmC WT level Small increase
R104A-CcmE WT level WT level
Q49A-CcmC/R104A-CcmE No holo-c550 Holo-CcmE accumulation
Q49R-CcmC/R104Q-CcmE WT level —
Q49E-CcmC WT level —
Q49I-CcmC/R104I-CcmE WT level —
Q49S-CcmC WT level —
R104S-CcmE WT level —
Q49S-CcmC/R104S-CcmE WT level —
Q49C-CcmC WT level —
R104C-CcmE WT level —
Q49C-CcmC/R104C-CcmE WT level —
Q49A-CcmC/R104V-CcmE No holo-c550 Holo-CcmE accumulation
Q49V-CcmC/R104A-CcmE No holo-c550 Holo-CcmE accumulation
Q49V-CcmC/R104V-CcmE No holo-c550 Holo-CcmE accumulation
Q49K-CcmC/R104A-CcmE WT level —
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broadening was only observed at the C terminus, especially
after residue 139. Whereas peaks for some of the residues can-
not be observed due to very low intensity (e.g.His130, where the
heme is bound) or cannot be included in the graph because of
peak overlap (positions 129, 135, 141, 144, and 149), it is clear
that the residues postulated by Enggist et al. (37) to form a
heme-binding pocket do not show any specific broadening;
Arg61 and Lys129 partially overlap with other residues, so they
were not included in the graph, but the intensity of the over-
lapped peaks is also not affected more than other core residues
by the presence of heme. We therefore conclude that the cova-
lent attachment of the heme to thisCcmEconstruct seems to be
affecting the very end of the flexible C terminus, whereas there
is no indication of a specific heme-binding site on the struc-
tured core of the protein.
The samplewe examined (same construct as the protein used
by Enggist et al. (37)), had a C-terminal His6 tag. Histidines are
known to act as heme ligands, so to assess whether the broad-
eningwe observed at theC terminus of the protein (Fig. 5A) was
due to the presence of the affinity tag, we also produced an in
vitro heme-reconstituted CcmE sample devoid of the His6 tag.
This was challenging because the His6 tag, although not essen-
tial, is useful for efficient heme attachment to the protein (46),
but it poses significant problems at the cleavage step. By fusing
a Streptavidin II tag after the His6 tag, we were able to produce
a fully reconstituted holo-CcmE sample without an affinity tag,
which we used to repeat the experiments described above. In
this case, oncemore, residues in the core of the protein, includ-
ing the ones postulated previously to form a heme-binding site,
remained unaffected by heme. In addition, residues at the C
terminus showed no significant broadening (Fig. 5B). This indi-
cates that when heme is covalently bound to His130 in CcmE, it
has very few specific interactions with the protein backbone.
Finally, we tested the overall flexibility of the protein back-
bone with and without attached heme using our initial His6-
tagged samples by {1H}-15N heteronuclear NOE experiments
(an example for apo-CcmE is shown in Fig. S4). For both sam-
ples, residues in the -sheet structure generally gave values
higher than 0.75, indicating a rigid backbone. Residues with
NOE values lower than 0.75 are either located at the N termi-
nus, which is expected as this protein is linked to a transmem-
brane helix in the cell, or at the C terminus. At the C terminus,
residue 128 is the first amino acid with a reduced NOE value
(0.68), and although we cannot measure values for residues 129
and 130, Asp131 has a significantly lower NOE ratio of 0.49,
suggesting that the protein is likely flexible from residue 128
onward. The fact that the results were similar for both apo- and
holo-samples also suggests that the presence of the attached
heme does not alter the flexibility of the protein.
Apo-CcmE does not have a heme-binding site on the
structured protein core
We found that there is no heme-binding site on the struc-
tured core of holo-CcmE. However, this species occurs after
covalent heme attachment and could well not require any fur-
ther interaction with the heme moiety. The most obvious way
to assess the noncovalent interaction of apo-CcmE with heme
would be to perform NMR experiments on a mixture of WT
Figure 4. The identified interaction site between CcmC and CcmE suggests that association of these two proteins is not driven by the presence of a
heme-binding site on the CcmE protein core. A, E. coli CcmC membrane topology model based on previously determined topologies (43). The WWD
heme-bindingmotif and the heme axial ligands (His60 andHis184) (22) are shown in green. The residues involved in the interactionwith CcmE, identified in this
study, are shown in cyan, and Gln49, which covaries with Arg104 in CcmE (42), is shown in blue. Heme is depicted by the red square. B, schematic representation
of the three-dimensional structure of leaderless WT E. coli CcmE (PDB entry 1SR3) determined by NMR spectroscopy (37); only one of the 20 NMR structural
conformers is displayed. Important residues are shown in a stick representation. His130 (red) binds heme covalently; Tyr134 (green) has been proposed to be an
axial ligand of the covalently bound heme (49, 50) and has been found to be important for cytochrome cmaturation (45, 48); Arg73, Asp101, and Glu105 (all in
cyan) form the interaction site of CcmEwith CcmC, identified in this study; andArg104 (blue) covarieswithGln49 of CcmC (42). Residues shown inmagenta (Ile34,
Phe37, Arg61, Val110, Leu127, and Lys129) have been previously proposed to form a CcmE heme-binding site (37).
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apo-CcmE and heme, soon after the heme addition. Unfortu-
nately, we found that for protein concentrations required for
NMRspectroscopy (minimumof 100M), the addition of heme
led to rapid (10-min) covalent heme attachment to the pro-
tein (Fig. S5, lane 1). This occurred even when we used WT
apo-CcmE devoid of its C-terminal His6 tag (Fig. S5, lane 2),
which has been shown previously to be slower in covalently
attaching heme in vitro (46). For this reason, we generated a
sample that mimics CcmE before heme attachment. We used
H130A-CcmE, which lacks its heme-binding histidine residue
and therefore is unable to bind heme covalently; this particular
CcmE variant has been used successfully in previous studies as
a mimic of the pre-adduct state of CcmE (35, 47). After purifi-
cation of the 15N-labeled apoprotein, we cleaved the His6 tag to
avoid any interference with heme binding, and we added an
excess of heme.After a short incubation,we removed the excess
heme through a rigorous wash process. The resulting sample,
shown in Fig. S6, contains heme bound to the protein nonco-
valently and can be used to assess whether apo-CcmE has a
specific heme-binding pocket before covalent heme attach-
ment.We repeated the same 1H-15NHSQCNMR experiments
we performed for WT holo-CcmE (Fig. 5, A and B), and once
more we found that there is no specific broadening in the struc-
tured core of the protein that would indicate a heme-binding
site (Fig. 5C).We note that comparison of these results with the
graph obtained for cleaved WT holo-CcmE (Fig. 5B), shows
that there is more specific broadening at the C terminus of
H130A-CcmE. Nonetheless, most of the broadening is around
Arg149, and very little broadening is observed for residues 130–
133, which are the site of covalent heme attachment in theWT
protein.
Discussion
The purification of the complex between heme-bound
CcmC and CcmE (22, 24), provided very important new
insights into the heme trafficking processes of System I. These
studies made clear that CcmE can attach heme covalently only
when in complex with CcmC and while the heme is ligated by
the essential CcmChistidines (His60 andHis184) (24). However,
the mechanistic drivers of the interaction between heme-
bound CcmC and apo-CcmE remained elusive until now, espe-
cially because the 3D structure of CcmC is still lacking. The use
of advanced in silico analyses was key for identifying potential
interacting residues between these two proteins. The work by
Ovchinnikov et al. (42) pinpointed in which region of each pro-
tein we should search for interacting residues, and by combin-
ing bioinformatics with in vivo experiments, we were able to
identify a protein–protein interaction site between CcmC and
CcmE consisting of six residues (Asp47, Gln50, and Arg55 on
CcmC; Arg73, Asp101, and Glu105 on CcmE). We found that
replacement of each of these amino acids with alanine led to
significant decrease in holo-CcmE and holocytochrome c for-
mation (Fig. 2, A and B), whereas the absence of all three resi-
dues on one of the interacting partners abolished System I func-
tion entirely (Fig. 2C). The latter proves that each of the
identified residues contributes to, and that they are collectively
essential for, the interaction of CcmCwith CcmE. The fact that
production of holocytochrome cmirrored holo-CcmEmatura-
tion for each of the variants (Fig. 2, A and B), further demon-
strates that these residues affect the association rather than the
dissociation of these two proteins. In addition, because single-
amino acid substitutions on either side of the interacting sur-
face (CcmC or CcmE) have the same effect (Fig. 2, A and B),
these six residues are potentially organized into three interact-
ing pairs. Based on the nature of the identified amino acids, one
of these interacting pairs likely involves Asp47 in CcmC and
Arg73 in CcmE.
Figure 5. Holo- and apo-CcmE do not have a heme-binding site on their
proteincore.A, observedpeak intensity ratios for 15N-labeled leaderless apo-
CcmE and holo-CcmE bearing a C-terminal His6 tag, obtained from HSQC
spectra collected at 750 MHz. Peak broadening, indicating interaction with
the heme moiety, is only observed at the C terminus of the protein and only
after residue 139. B, observed peak intensity ratios for 15N-labeled leaderless
apo-CcmE and holo-CcmE without an affinity tag, obtained at 600 MHz.
Almost no specific peak broadening is observed, showing that the heme has
very few interactions with the protein backbone. C, observed peak intensity
ratios for 15N-labeled leaderless H130A-apo-CcmE and H130A-holo-CcmE
without an affinity tag, obtained at 750 MHz. Peak broadening is only
observed at the C terminus of the protein, near residue 149. For all panels, the
solid red line indicates the average peak ratio for residues 33–130, and the
dotted red lines indicate theminimumandmaximumvalueswithin one S.D. of
this average. In A and B, the red arrows indicate the residues previously pro-
posed to form a CcmE heme-binding site for holo-CcmE (37). Residues for
which intensity ratios are not shown correspond either to prolines or to resi-
dues with overlapping or very weak peaks in the HSQC spectrum of apo-
CcmE. For each residue, peak intensity ratios derived from two independent
experiments are shown. Errors for each experiment (error bars) were derived
from the Monte Carlo analysis of baseline noise.
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Visualization of the three identified interacting residues
(Arg73, Asp101, and Glu105) on the structure of CcmE (Fig. 6)
reveals a relatively large interaction interface for the periplas-
mic domain of this protein. Although we cannot exclude the
contribution of other residues to this interaction interface,
careful examination of the CcmE structure showed that only
two additional residues, Leu78 and Ile98 (Fig. 6, magenta), are
sufficiently surface-exposed and have side chains with the right
orientation to be part of it. These are nonpolar residues. There-
fore, if indeed they were involved in the interaction of CcmE
with CcmC, they would most likely contribute weaker van der
Waals interactionswith their partners onCcmC. In the absence
of a structure for the latter, it is not possible to venture a
guess regarding which CcmC residues Leu78 and Ile98 of
CcmE could be interacting with. We also note here that the
six residues we identified are likely not the sole determinant
of the overall CcmC–CcmE interaction. Whereas they are
certainly extremely important for the association of the
periplasmic domain of apo-CcmE with the periplasmic portion
of heme-bound CcmC, as confirmed by the dramatic pheno-
types observed by their substitution (Fig. 2), the proteins of
System I are thought to generally associate with each other,
forming either one large supercomplex or several smaller com-
plexes (21, 35). These interactions are no doubt also driven by
the membrane-embedded domains of these proteins, although
exact mechanistic evidence is not yet available.
When it came to the pair of covarying residues, CcmCGln49
and CcmE Arg104, their role was not immediately obvious. We
performed a series of mutagenesis experiments, which did not
affect any of the System I functions that we were able to assess
(Table 1). It was only when both residues were replaced by
nonpolar amino acids that a phenotype was observed (Fig. 3, A
and D). Replacement of these residues with alanines or valines
led to impressive accumulation of holo-CcmEand the complete
absence of holocytochrome c formation, strongly reminiscent
of the K40D-CcmA-System I phenotype (26, 27). This suggests
that although holo-CcmE successfully formed, it could not be
released from the CcmC–heme–CcmE complex, despite the
fact that CcmABwere present and functional. As the covarying
residues are located within the CcmC–CcmE interaction site, a
plausible explanation for this phenotype is that they also inter-
act, as predicted by Ovchinnikov et al. (42), and their role is a
steric one. More specifically, their presence would ensure that
during CcmC–CcmE association, these two proteins do not
interact too tightly; otherwise, the action of CcmAB would not
be sufficient to allow release of holo-CcmE. This hypothesis is
supported by our bioinformatics data (Table S2), which show
that although there is a significant variation in the amino acids
found at these positions in related bacterial species, the combi-
nations leading to the phenotype we observed (A-A, A-V, V-A,
and V-V) are never found. The proposed steric role for these
residues makes sense if one considers that although CcmC and
CcmE interact with high affinity (22, 24), the CcmC–heme–
CcmE complex has to be eventually resolved for cytochrome c
to be matured.
The question of whether CcmE interacts with heme-bound
CcmC through a heme–protein interaction mediated by a
heme-binding site on CcmE has been a longstanding one. On
the one hand, this assumption is a logical one for a “heme chap-
erone”; hence, the attempts to detect such an interaction site
(37, 44–46) are justified. On the other hand, none of the afore-
mentioned studies produced convincing data that proved the
presence of such a site. We found that apo- and holo-CcmE do
not have a heme-binding site in the core of the protein (Fig. 5).
WT holo-CcmE shows some specific broadening at the very
end of its C terminuswhen it bears aHis6 tag and no interaction
with its attached heme when cleaved of its affinity tag. The
protein core of His130-holo-CcmE, which we use as a mimic of
the protein before covalent bond formation, was also not found
to interact with the heme moiety. Although there is some
broadening at the C terminus, there is no interaction of the
heme with the structured part of CcmE, and certainly there is
no detectable CcmE heme-binding pocket on the main body of
the protein. The results of our NMR analysis agree with the
findings of our in vivo experiments, wherewe showed that asso-
ciation of CcmC with CcmE occurs through protein–protein
rather than protein–heme interactions and are not surprising if
one interprets themwith the in vivo function of CcmE inmind.
For the pre-adduct species, it is important to consider that this
protein attaches heme covalently while already in association
with heme-bound CcmC in a stable complex and while the
heme cofactor is ligated to twohistidine residues onCcmC (24).
For holo-CcmE, the lack of a heme-binding site is also unsur-
prising. In vivo this species is binding the heme stably through
its unique covalent bond and needs to pass it on to the substrate
apocytochrome. In this context, a heme-binding site on the
structured core of the periplasmic domain of CcmE would
likely be detrimental to the overall role of this protein, as it
would not facilitate the transfer step of the heme to the
apocytochrome.
CcmC–CcmE interactionmodel
Using covariance and bioinformatics analyses, in vivo exper-
iments on the entire System I operon, and NMR spectroscopy,
we can propose for the first time a mechanistic model (Fig. 7)
for the interaction of CcmC with CcmE leading to holo-CcmE
formation.We suggest the following sequence of events. CcmC
sources the heme for System I and binds it through its WWD
motif and through ligation via two conserved histidine residues,
Figure 6. Arg73, Asp101, Glu105 (in cyan), and Arg104 (in blue) form a rela-
tively large interaction interface on the periplasmic domain of CcmE.
Only two additional residues near the identified interaction site of CcmE,
Leu78 and Ile98 (in magenta), are sufficiently surface-exposed and have side
chains with the right orientation to potentially be part of this interaction
interface. Shown is a schematic representationof the3Dstructureof leaderless
WT E. coli CcmE (PDB entry 1SR3) determined by NMR spectroscopy (37) (left,
cartoon representation of the backbone and stick representation of residues of
interest; right, space-filled representation in the same orientation).
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His60 and His184 in E. coli (22, 24) (Fig. 7, step 1). CcmE associ-
ates with heme-bound CcmC via three pairs of interacting res-
idues (Asp47, Gln50, and Arg55 on CcmC; Arg73, Asp101, and
Glu105 on CcmE) forming a stable CcmC–heme–CcmE com-
plex. During this association, Gln49 and Arg104 in CcmC and
CcmE, respectively, also interact, exerting a steric role within
the CcmC–CcmE interaction interface that prevents the two
proteins from binding too tightly to each other and makes the
subsequent release of holo-CcmE possible (Fig. 7, step 2). In the
CcmC–heme–CcmE complex environment, theCcmC–CcmE
interaction places CcmE in an optimal position for covalent
heme attachment. Its flexible tail is brought into proximity of
the heme moiety by the interaction interface and is likely fur-
ther oriented toward the heme by Tyr134 (Fig. 7, step 3). Tyr134
is almost entirely conserved (in3% of cases, it is a Phe, also a
plausible heme ligand), and, although not essential, it has been
shown to be important for efficient holo-CcmE production (45,
48) and has been proposed to be the heme ligand after holo-
CcmE release (49, 50). It can be envisaged that the proximity of
His130 to the heme at this point would be sufficient for covalent
bond formation through a Michael addition or an imidazole
cation radical mechanism (19).
In the absence of high-resolution structures for most of the
System I components, studies like this contribute significantly
to our understanding of the mechanistic details of this multi-
protein system. Our model (Fig. 7) provides important new
insight into one of the crucial steps of cytochrome c biogenesis
as performed by System I, which not only operates in Gram-
negative bacteria but is also found in the mitochondria of most
photosynthetic eukaryotes. In addition, our results demon-
strate the great potential of in silico predictions for the study of
complex protein–protein interactions. A similar approach
could be followed to elaborate further the interaction of mito-
chondrial apo-cytochrome c with its maturation apparatus in
most nonphotosynthetic eukaryotes, a single protein called
holocytochrome c synthase (HCCS). Despite important recent
progress in this research direction (51), the structure of HCCS
remains unknown, and therefore gaining residue-specific
insight in the maturation process is challenging. Use of cova-
riance and bioinformatics methods could reveal which parts
of HCCS are involved in the interaction with its substrate
apocytochrome.
Experimental procedures
Construction of plasmids
Plasmids and oligonucleotides used in this study are listed in
Tables S3 and S4, respectively. All constructs, with the excep-
tion of pQE2-Im9 and pCcmC1, were produced by site-di-
rected mutagenesis (QuikChange, Stratagene) using plasmid
pE221 (52) or pEC86 (53) as template. pQE2-Im9was generated
by amplifying the gene of the immunity protein of colicin E9
(immunity 9) from E. coli genomicDNAusing oligonucleotides
P1 and P2 and ligating it into AseI-SphI–digested TAGZyme
pQE vector (pQE-2, Qiagen). The resulting expression vector
encodes an N-terminal polyhistidine tag, followed by the
immunity 9 gene and a Factor Xa cleavage site before the mul-
tiple cloning site of TAGZyme pQE. pCcmC1was generated by
amplifying E. coli ccmC from pEC86 using oligonucleotides P3
and P4 and ligating it into NdeI-HindIII–digested pQE2-Im9
(Table S3). DNAmanipulationswere conducted using standard
methods. Oligonucleotides were purchased from Sigma Geno-
sys. KODHot StartDNApolymerase (Novagen)was used for all
PCRs, enzymeswere purchased fromNewEnglandBiolabs, and
all constructs were sequenced before use.
Cell growth and fractionation
Bacterial strains used in this study are listed in Table S1. Cell
growth and fractionation for in vivo experiments were carried
out as follows. Experiments were performed in the WT E. coli
strain JCB38725 (54). The E. coli ccm operon or its variants
were constitutively expressed from plasmid pEC86 or its deriv-
ative plasmids generated in this study, respectively (Table S3).
Paracoccus denitrificans cytochrome c550 was co-expressed
with the E. coli ccm operon (or its variants) from plasmid
pKPD1 (55). E. coli ccmC or its variants were expressed from
Figure 7. Schematic representation of the proposed mechanism for the
interaction of CcmE with heme-bound CcmC and for the subsequent
covalent heme attachment to CcmE. Heme is depicted as a red square, and
CcmE His130, which binds heme covalently, is shown as a red circle. Residues
that ligate heme (CcmE Tyr134; CcmC His60 and His184) or bind heme nonco-
valently (CcmCWWDmotif) are shown in green. The interaction site between
CcmC and CcmE is marked in cyan on both proteins. Covalent bonds involv-
ing the hememoiety are displayed by a solid line, and heme ligation is shown
by dotted lines. The sequence of events is proposed to be as follows. 1, CcmC
ligates heme through two histidine residues (His60 and His184) flanking the
WWDmotif (green circles and arch) (22). 2, heme-boundCcmCassociateswith
apo-CcmE through three pairs of residues, Asp47, Gln50, and Arg55 located on
the first periplasmic loop of CcmC and Arg73, Asp101, and Glu105 located on a
loop of the -barrel core of CcmE (see also Fig. 4), forming a stable CcmC–
heme–CcmE complex (22, 24). During this step, Gln49 of CcmC and Arg104 of
CcmE (covarying pair) play a steric role, ensuring that the association of the
two proteins is optimal. 3, after the CcmC–heme–CcmE complex is formed,
the flexibleC-terminal tail of CcmE ispositionednear theheme, likely through
interaction with Tyr134 (45, 48–50), and this environment of high proximity
leads to covalent attachmentofheme toHis130 ofCcmE.AsCcmD isnot found
tobeessential for formationofholo-CcmE in the context of theCcmC–heme–
CcmE complex (41), it has been omitted from this model.
Mapping the CcmC–CcmE interaction in System I
16786 J. Biol. Chem. (2018) 293(43) 16778–16790
 at U
niversitÃƒÂ© de Lausanne on November 15, 2018
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
plasmids pCcmC1 or pSHS47–49, respectively (Table S3), spe-
cifically for assessing total CcmC amounts. In all cases, cell
growth was conducted in 200 ml of 2TY medium (16 g/liter
peptone, 10 g/liter yeast extract, and 5 g/liter NaCl) in 2.5-liter
flasks; the small culture volumes ensured sufficient aeration,
preventing expression of the endogenous E. coli ccm genes.
Cultures were inoculated from single colonies and incubated at
37 °C for 15–18 h with shaking at 200 rpm. 1 mM isopropyl-1-
thio--D-galactopyranoside was added to the cultures from
inoculation. 100 g/ml ampicillin and 34 g/ml chloramphen-
icol were usedwhen appropriate. For the extraction of periplas-
mic fractions, cells were harvested and spheroplasted as
described by Allen et al. (56). For the isolation of the crude
membrane fractions, a French press was used. Disruption of the
cells was performed at 16,000 p.s.i., followed by centrifugation
at 257,000  g for 1 h at 4 °C. The membrane fraction was
resuspended in 25 ml of 50 mM Tris-HCl (pH 7.5), 150 mM
NaCl and was centrifuged again as above. The washed crude
membrane fraction was resuspended in 1–2 ml of 50 mM Tris-
HCl (pH 7.5), 150 mM NaCl.
Cell growth and fractionation for protein production and
purification were carried out as follows. E. coli BL21 (DE3)
(Stratagene) were transformed with plasmid pE221 (52) or its
derivative plasmids generated in this study (pSHS04, pSHS05,
and pSHS10; Table S3) expressing leaderless (Ser32–Ser163)
E. coli CcmE. Transformants were initially grown on lysogeny
broth (LB; 10 g/liter peptone, 5 g/liter yeast extract, 10 g/liter
NaCl) agar plates supplemented with 100g/ml ampicillin. For
production of unlabeled protein samples, transformants were
subsequently used to inoculate small-scale overnight cultures
(5 ml of LB) in 50-ml polypropylene tubes, supplemented with
100 g/ml ampicillin, and incubated at 37 °C with shaking at
200 rpm for 15–18 h. 500 ml of LB in 2.5-liter flasks were then
inoculated from the overnight cultures (1:250), and the result-
ing suspensions were incubated at 37 °C with shaking at 200
rpm until A600  0.8. 1 mM isopropyl-1-thio--D-galactopyra-
noside was used for protein induction, and cultures were fur-
ther grown at 30 °C with shaking at 200 rpm for 15 h. For the
production of 15N-labeled protein samples, cell growth and
protein induction were carried out as described in previous
work (57). For all cultures, after harvesting, the periplasmic
fraction was isolated as described above.
Apo-CcmE purification and in vitro reconstitution with heme
Unlabeled or 15N-labeled WT or H130A leaderless E. coli
apo-CcmE was purified as follows. Cells were grown as
described above, and, after isolation, the periplasmic fraction
was applied onto 10 ml of Fast Flow Chelating Sepharose
(Amersham Biosciences) charged with Ni2 and equilibrated
with 50 mM Tris-HCl (pH 7.5), 300 mM NaCl. The column was
washedwith the equilibration buffer, and apo-CcmEwas eluted
with 50 mM Tris-HCl (pH 7.5), 300 mM NaCl, 200 mM imidaz-
ole. The eluent was exchanged into 50 mM Tris-HCl (pH 7.5),
150 mM NaCl and concentrated. Thrombin cleavage of the
affinity tag, when necessary, was performed using the Throm-
bin CleanCleave kit (Sigma) according to the manufacturer’s
instructions.
WTholo-CcmE bearing a C-terminal His6 tag was generated
by in vitro reconstitution of the purified apoprotein (from plas-
mid pE221; Table S3) with heme, as follows. A 5-fold excess of
hemin (Sigma-Aldrich; dissolved in DMSO) was added into a 1
mM protein solution along with 2 mM disodium dithionite. The
reactions were carried out in the dark and at room temperature
under humidified argon gas for 16–18 h. Unbound heme was
removed by incubating the reaction mixtures in the dark with
equal volumes of 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 2 M
imidazole for 16–18 h at 4 °C. Excess imidazole and unbound
heme were removed by applying the reaction mixture to a
desalting column (0.6 15 cm) packed with hydrated BIO-Gel
P-6 DG resin (Bio-Rad).
WT holo-CcmE without an affinity tag was generated
through a multistep in vitro heme reconstitution process.
Whereas the presence of the His6 tag is important for efficient
and timely covalent heme attachment, it causes significant pro-
tein loss at the cleavage step. Thus, a construct bearing a C-ter-
minal His6 tag preceded by a thrombin cleavage site and fol-
lowed by a Strep-II tag was used (pSHS05; Table S3). The
apoprotein was produced as described above and purified
through its C-terminal His6 tag. Subsequently, covalent heme
attachment and thrombin cleavage were performed as
described above. After the cleavage reaction, the cleaved affin-
ity tag was removed by applying the reactionmixture onto 5ml
of Strep-Tactin Sepharose (IBA), equilibrated with 50mMTris-
HCl (pH 7.5), 150 mM NaCl. The flow-through was collected,
and the resin was further washed with the equilibration buffer.
Although this step led to60–70% protein loss, due to associ-
ation of the heme of holo-CcmE with the His6 tag that was
bound on the affinity column, a sufficient amount of cleaved
protein for NMR spectroscopy was recovered.
H130A-holo-CcmE devoid of a His6 tag was generated by in
vitro reconstitution of the purified apoprotein (from plasmid
pSHS10; Table S3) with heme, as follows. H130A-apo-CcmE
cleaved of its C-terminal His6 tag was mixed with excess heme
(Sigma-Aldrich; dissolved in DMSO) and incubated at room
temperature for 30 min. The excess heme and DMSO were
subsequently removed by buffer exchange in a concentrating
device using 50 mM Tris-HCl (pH 7.5), 150 mM NaCl.
Characterization of pure protein samples
Protein concentration was determined using the Pierce BCA
Reducing Agent Compatible Protein Assay Kit (Thermo Fisher
Scientific). All purified proteins were subjected to SDS-PAGE
analysis and electrospray ionization MS (ESI-MS) to confirm
that they were pure and of the expected masses. SDS-PAGE
analysis was carried out on 10% BisTris NuPAGE gels (Thermo
Fisher Scientific) with prestained molecular weight markers
(SeeBlue Plus 2; Thermo Fisher Scientific). All samples were
denatured at 100 °C for 2 min. Simply Blue Safe stain (Thermo
Fisher Scientific) was used for staining gels for total protein
content. For detection of proteins with covalently bound heme,
the method of Goodhew et al. (58) was used; for WT holo-
CcmE protein solutions, this method was used to initially con-
firm that the reconstitution of apo-CcmE with heme was suc-
cessful. ESI-MS was performed using aMicromass Bio-Q II-ZS
triple quadrupole mass spectrometer (10-l protein samples in
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1:1water/acetonitrile, 1% (v/v) formic acid at a concentration of
20 pmol/l were injected into the electrospray source at a flow
rate of 10 l/min). For WT holo-CcmE protein solutions,
ESI-MS was used as a definitive method to assess whether the
protein was fully reconstituted with heme.
Apo- and holo-WT CcmE solutions were found to be folded
as they gave well dispersed NMR spectra (Fig. S3B; details for
acquisition of spectra are given below). The backbone chemical
shifts of WT apo-CcmE recorded by 2D 1H-15N HSQC spec-
troscopy are in agreement with the published chemical shifts
used for structural determination of apo-CcmE (37). The spec-
trum of the holoprotein is largely similar to that of apo-CcmE,
showing that covalent heme attachment does not affect its
overall fold.
The protocol for in vitro reconstitution of apo-CcmE with
heme has been shown previously to produce fully functional
protein able to transfer its heme to an apocytochrome (52).
Nonetheless, and in addition to MS, which confirmed the cor-
rectmasses for all apo- and holo-samples, holo-CcmE solutions
were also assessed by visible absorption spectra on a Varian
Cary 50 Bio spectrophotometer (Fig. S3A). Sample reduction
was performed by the addition of several grains of sodium
dithionite. In addition, absorption spectra in the presence of
hydroxide and pyridine in reducing heme conditions were
obtained (Fig. S3A, inset) according to the method of Bartsch
(59). The latter are characteristic of the type of iron-porphyrin
present as well as of any modifications to it. For all in vitro-
reconstitutedWT holo-CcmE samples, the same heme attach-
ment as in naturally occurring CcmE (25) was observed.
Characterization of periplasmic andmembrane fractions
Production of cytochrome c550 was assessed by SDS-PAGE
analysis of periplasmic fractions, followed by detection of pro-
teins with covalently bound heme. Periplasmic extraction (56),
SDS-PAGE analysis, and heme staining (58) were performed as
described above. Gel loadings were normalized according to
wet cell pellet weights, and samples were denatured at 100 °C
for 2 min. At least six replicates of each experiment were
conducted.
Production of holo-CcmE was assessed by SDS-PAGE anal-
ysis of membrane fractions, followed by detection of proteins
with covalently bound heme. Isolation of the crude membrane
fractions, SDS-PAGEanalysis, andheme staining (58)were per-
formed as described above. Gel loadings were normalized
according to the total protein content of themembrane suspen-
sions, determined using the Pierce BCA Reducing Agent Com-
patible Protein Assay Kit (Thermo Fisher Scientific), and sam-
ples were denatured by incubation at 42 °C for 5 min. At least
three replicates of each experiment were conducted.
Immunoblotting was carried out following SDS-PAGE anal-
ysis by transferring the proteins onto nitrocellulose (Hybond
C-Extra, Amersham Biosciences). Blocking was performed
with 5% (w/v) skimmed milk powder in TBS (50 mM Tris-HCl
(pH 7.5), 120mMNaCl, 0.1% (v/v) Tween 20). For the detection
of total CcmE amounts in crude membrane fractions, rabbit
antiserum raised against E. coli CcmE (Covalab) (dilution
1:1000) was used, followed by mouse anti-rabbit alkaline
phosphatase–conjugated antibody (Sigma) (dilution 1:30,000).
For the detection of total CcmC amounts in crude membrane
fractions, a penta-His horseradish peroxidase alkaline phos-
phatase–conjugated mAb (Sigma) (dilution 1:2000) was used.
Development was carried out using a SigmaFast 5-bromo-4-
chloro-3-indolyl phosphate/nitro blue tetrazolium tablet
(Sigma) in both cases. At least three replicates of each experi-
ment were conducted.
NMR spectroscopy
NMR experiments were carried out using spectrometers
operating at 1H frequencies of 600 and 750 MHz. The spec-
trometers were equipped with Oxford Instruments magnets
and home-built triple-resonance pulsed-field gradient probes
(750 MHz) or with Bruker Avance consoles and TCI Cryo-
Probes (600 and 750 MHz). NMR data were acquired using
either GE/Omega software with pulse sequences written in-
house or Topspin software and pulse sequences provided in the
Topspin libraries from Bruker Biospin. NMR data were pro-
cessed using NMRPipe (60), and spectra were analyzed using
theCCPN software (61). Protein samples were prepared at con-
centrations of0.3–1.2 mM in 25 mM Tris (95:5, H2O/D2O), at
pH values ranging from 5.5 to 7.5. All experiments were con-
ducted at 25 °C.
2D 1H-15N HSQC spectra were recorded at 600 MHz with
spectral widths of 7,575.76 and 1,901.14 Hz in the 1H and 15N
dimensions, respectively, or at 750MHzwith spectral widths of
9,433.96 and 2,380.95Hz in the 1H and 15Ndimensions, respec-
tively. HSQC data sets were collected with 128 and 1024 com-
plex points in F1 (15N) and F2 (1H), respectively. The peak
height ratios shown in Fig. 5 were calculated as the ratio of the
peak intensities in the spectra recorded for the holo- and apo-
proteins. Peak heights were determined using the CCPN Anal-
ysis software (61). Uncertainties in the peak height ratios were
estimated from500MonteCarlo simulations using the baseline
noise as a measure of the error in the peak heights. Two
replicates of each experiment were collected and are plotted
in Fig. 5.
The {1H}-15N heteronuclear NOE experiments were re-
corded with and without 1H saturation for 4 s at 750MHz in an
interleavedmanner. The data setswere acquired using the same
sweep widths and numbers of data points as for the HSQC
experiments. The {1H}-15N NOE was calculated as the ratio of
the peak intensities in the spectra recordedwith andwithout 1H
saturation. Peak heights and errors in the {1H}-15N NOE were
determined as described above.
Resonance assignments
Resonance assignments for E. coli CcmE have been reported
previously at pH 7.2 in 50mM sodium phosphate, 300mMNaCl
at 30 °C (BMRB accession number 6723) (37). These assign-
ments were used as the starting point for assignment of the
HSQC spectrum of WT apo-CcmE (with and without a C-ter-
minal His6 tag) and H130A-apo-CcmE (without a C-terminal
His6 tag) at 25 °C at pH values ranging from 5.5 to 7.5. Assign-
ments under our solution conditions were confirmed using 3D
15N-edited total correlation spectroscopy-HSQC and NOESY-
HSQC data sets.
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Bioinformatics
To assess the conservation of E. coliCcmC or CcmE residues
of interest, 2,753 bacterial and archaeal representative pro-
teomes from theNCBI database were searched for homologs of
E. coli CcmC or CcmE, respectively, using blastp 2.2.28
(NCBI) (62) (e value 0.01, identity 20%, coverage 50%).
Hits were used as a blastp query against the E. coli MG1655
proteome (e value 0.01), and only the ones giving CcmC or
CcmE as best-hit results were retained. The sequences were
aligned using MUSCLE version 3.8.31 (63) and checked manu-
ally for consistency. The retained sequences were clustered
using ucluster version 7.0 (identity 0.2) (64), and representa-
tive sequences of the main clusters were selected and aligned
along with the E. coliMG1655 CcmC or CcmE homolog using
MUSCLE 3.8.31.
To identify amino acids found in positions corresponding to
Gln49 and Arg104 of E. coli CcmC and CcmE, respectively, in
other Gram-negative bacteria, the same search procedure was
used using blastp with e value1E5, identity40%, and cov-
erage 80%. A total of 628 were retrieved. Sequences were
aligned using MUSCLE 3.8.31 (63), and residues in positions
corresponding to Gln49 and Arg104 in the E. coli MG1655
CcmC and CcmE homologs, respectively, were retrieved. The
frequency of occurrence of each pair was subsequently calcu-
lated on the subset of sequences from - and -proteobacteria
to avoid confounding effects due to excessive divergence.
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